Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.54 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 2/20 | 0.48 |
| ▸ | NOS1 | P29475 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.47 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15831192 | 0.93 | MAPT (0.64) | MAPTRAB9AHPGDKMT2ALMNA | |
| SCHEMBL20836631 | 0.87 | HPGD (0.79) | MAPTRAB9AHPGDKMT2ALMNA | |
| SCHEMBL18867234 | 0.87 | MAPT (0.68) | MAPTRAB9AHPGDKMT2ALMNA | |
| SCHEMBL68148 | 0.85 | ALDH1A1 (0.59) | MAPTHPGDLMNAALDH1A1HTT | |
| SCHEMBL20587670 | 0.85 | ALDH1A1 (0.59) | MAPTHPGDLMNAALDH1A1HTT | |
| SCHEMBL50646 | 0.85 | MAPT (0.68) | MAPTRAB9AHPGDKMT2ALMNA | |
| SCHEMBL12123514 | 0.85 | MAPT (0.53) | MAPTRAB9AHPGDKMT2ALMNA | |
| SCHEMBL6758498 | 0.82 | ALDH1A1 (0.64) | MAPTHPGDLMNAALDH1A1HTT | |
| SCHEMBL28787222 | 0.82 | ALDH1A1 (0.56) | MAPTHPGDLMNAALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL2362644 | 0.82 | ALDH1A1 (0.56) | MAPTHPGDLMNAALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0639559-B1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM & HAAS (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | claimed |
| US-12497417-B2 | Delivery systems for controlled drug release | LADRX CORPORATION (US) | 2025-12-16 | — | — | US | disclosed |
| CN-119684287-A | 4- (3- (Piperidin-4-yl) -1H-pyrazol-5-yl) -1H-pyrrole [2,3-b ] pyridine derivative, and preparation method and application thereof | 烟台新药创制山东省实验室 | 2025-03-25 | — | — | CN | disclosed |
| US-20230279286-A1 | PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS | ExxonMobil Technology and Engineering Company (US) | 2023-09-07 | — | — | US | disclosed |
| CN-110461820-B | Organic luminophores | 香港科技大学 | 2023-07-21 | — | — | CN | disclosed |
| EP-4206176-A1 | METHOD FOR PREPARING 1,4-BIS(4-PHENOXYBENZOYL)BENZENE AND 1,4-BIS(4-PHENOXYBENZOYL)BENZENE PREPARED THEREBY | Hanwha Solutions Corporation (KR) | 2023-07-05 | — | — | EP | disclosed |
| EP-4137538-A1 | POLYAMIDE-IMIDE-BASED FILM, PREPARATION METHOD THEREOF, AND COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | SKC Co., Ltd. (KR) | 2023-02-22 | — | — | EP | disclosed |
| US-20230023537-A1 | DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | LADRX CORPORATION | 2023-01-26 | — | — | US | disclosed |
| CN-115089722-A | Delivery system for controlled drug release | 森托瑞恩生物制药公司 | 2022-09-23 | — | — | CN | disclosed |
| US-20220243061-A1 | POLYAMIDE-IMIDE FILM, PREPARATION METHOD THEREOF, COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | MICROWORKS SOLUTIONS CO., LTD. (KR) | 2022-08-04 | — | — | US | disclosed |
| US-5397798-A | Benzamide and sulfonamide hypoglycemic agents | ELI LILLY AND COMPANY (US) | 1995-03-14 | — | — | US | disclosed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | disclosed |
| WO-1994018186-A1 | SYNTHESIS OF TAXOL, ANALOGS AND INTERMEDIATES WITH VARIABLE A-RING SIDE CHAINS | BRYN MAWR COLLEGE (US) | 1994-08-18 | — | — | WO | disclosed |
| US-5290950-A | Containing chromophore and ionophore groups, complexing metals, analysis of body fluids | WAYNE STATE UNIVERSITY (US) | 1994-03-01 | — | — | US | disclosed |
| EP-0491525-A1 | Benzamide and sulfonamide hypoglycemic agents | ELI LILLY AND COMPANY (US) | 1992-06-24 | — | — | EP | disclosed |
| US-5096832-A | Complexing, spectrophotometry | WAYNE STATE UNIVERSITY (US) | 1992-03-17 | — | — | US | disclosed |
| US-4139717-A | 1,3-Dicarbonyl compounds | TEIJIN LIMITED (JP) | 1979-02-13 | — | — | US | disclosed |
| US-4009196-A | HYPOTENSIVE AGENTS, BRONCHODILATORS, PROSTAGLANDIN ANALOGS | TEIJIN LIMITED (JA) | 1977-02-22 | — | — | US | disclosed |
| US-3954852-A | Indenylacetic acid compounds | MERCK & CO., INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230023537-A1 | DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | ABCB11, SLC10A1, SLC5A1 | MAPT 565/4885RAB9A 1629/4885HPGD 662/4885 |
| US-12497417-B2 | Delivery systems for controlled drug release | ABCB11, SLC10A1, SLC5A1 | MAPT 565/4885RAB9A 1629/4885HPGD 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.